Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
CCTA: Participants will be examined with CCTA during admission.
Conventional ICA: Patients will be examined with conventional standard-of-care ICA.
Team-based interventional triage: The CCTA will be discussed at a coronary CT-team conference to establish the treatment strategy and provide guidance for any necessary interventional procedure.
Study summary
Coronary computed tomography angiography (CCTA) is a widely accepted initial diagnostic test for individuals suspected of having chronic coronary syndromes. However, there is limited evidence supporting its use in the acute setting. So far, no large-scale randomized trial has examined the performance of CCTA as an alternative to invasive coronary angiography (ICA) in individuals with non-ST-segment elevation myocardial infarction (NSTEACS).
If CCTA were to replace ICA as a routine procedure for individuals with NSTEACS, it could reduce the risk of complications related to ICA, improve patient comfort, expedite decision-making, and reduce healthcare expenses and interhospital transfers.
Eligibility
Primary outcome measure(s)
- Number of participants with a combined endpoint of major adverse cardiac events — At 1 year.
All-cause mortality, non-fatal myocardial infarction, hospitalization with refractory angina, or hospitalization with heart failure.
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Herlev and Gentofte Hospital | Copenhagen | Hellerup | Recruiting |
| Bispebjerg Hospital | Bispebjerg | Denmark | Recruiting |
| Rigshospitalet | Copenhagen | Denmark | Recruiting |
| Zealand University Hospital | Copenhagen | Denmark | Recruiting |
| North Zealand Hospital | Hillerød | Denmark | Recruiting |
| Hvidovre Hospital | Hvidovre | Denmark | Recruiting |
More Copenhagen University Hospital, Rigshospitalet trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06101862 on ClinicalTrials.gov ↗ ← All trials in Denmark